INBX
Inhibrx Biosciences, Inc.
97.00$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,273.1% | -100.0% | – | -100.0% | – | -100.0% | – | -100.0% | – | – | – | – | |
| – | -2.0% | +20.8% | +31.9% | +60.0% | -9.3% | -2.0% | -1.9% | -12.1% | -3.1% | -4.8% | – | – | |
| – | – | -126.9% | – | -860.0% | – | – | – | -191.2% | – | – | – | – | |
| – | +115.0% | -22.3% | +6.3% | -43.5% | -12.7% | +10.5% | -39.6% | +28.1% | -11.2% | -2.6% | -3.2% | – | |
| – | -0.7% | +27.3% | +836.1% | -91.5% | +110.8% | -63.8% | +6.6% | -17.8% | +5.6% | +2.4% | +44.5% | – | |
| – | +96.4% | -18.0% | +119.1% | -71.4% | +7.2% | -14.4% | -33.6% | +18.6% | -8.6% | +0.1% | +5.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | -1.1% | -34.1% | -100.0% | – | – | +16.8% | +1.3% | +0.1% | +10.2% | +62.2% | – | |
| – | – | – | – | -102.4% | – | – | – | – | – | – | – | – | |
| – | -300.0% | – | -99.4% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -102.4% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -102.3% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.